Tiziana Life Sciences PLC(TLSA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TLSA Tiziana Life Sciences PLC

Market Closed 10-16 16:00:00 EDT

1.05

+0.00

0.00%

盘后1.13

+0.08+7.62%

19:48 EDT

High1.10	Low1.03	Vol563.22K
Open1.08	D1 Closing1.05	Amplitude6.67%
Mkt Cap133.35M	Tradable Cap67.02M	Total Shares127.00M
T/O598.89K	T/O Rate0.88%	Tradable Shares63.83M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TLSA","market":"US","secType":"STK","nameCN":"Tiziana Life Sciences PLC","latestPrice":1.05,"timestamp":1792180800000,"preClose":1.05,"halted":0,"volume":563220,"hourTrading":{"tag":"盘后","latestPrice":1.13,"preClose":1.05,"latestTime":"19:48 EDT","volume":12152,"amount":13039.4603,"timestamp":1792194510515,"change":0.08,"changeRate":0.07619,"amplitude":0.085714},"delay":0,"changeRate":0,"floatShares":63832528,"shares":127000000,"eps":-0.155821,"marketStatus":"Market Closed","change":0,"latestTime":"10-16 16:00:00 EDT","open":1.08,"high":1.1,"low":1.03,"amount":598892.10192,"amplitude":0.066667,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.155821,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1792396800000},"marketStatusCode":7,"adr":0,"adrRate":2,"listingDate":1542690000000,"exchange":"NASDAQ","adjPreClose":1.05,"preHourTrading":{"tag":"盘前","latestPrice":1.1292,"preClose":1.05,"latestTime":"09:18 EDT","volume":16575,"amount":17756.5969425,"timestamp":1792156734011,"change":0.0792,"changeRate":0.075429,"amplitude":0.104762},"postHourTrading":{"tag":"盘后","latestPrice":1.13,"preClose":1.05,"latestTime":"19:48 EDT","volume":12152,"amount":13039.4603,"timestamp":1792194510515,"change":0.08,"changeRate":0.07619,"amplitude":0.085714},"volumeRatio":0.6503352242684002,"impliedVol":1.1411,"impliedVolPercentile":0.8924},"requestUrl":"/m/hq/s/TLSA/wiki","defaultTab":"wiki","newsList":[{"id":"2675592486","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2675592486","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675592486?lang=en_us&edition=fundamental","pubTime":"2026-10-16 20:57","pubTimestamp":1792155426,"startTime":"0","endTime":"0","summary":"Healthcare stocks were edging higher premarket Friday, with the State Street Health Care Select Sector SPDR ETF  up 0.4% and the iShares Biotechnology ETF  advancing by 0.5%.Tiziana Life Sciences  stock was up more than 1% after the company said it has started dosing the last patient in the phase 2 trial of intranasal foralumab in patients with early/mild Alzheimer's disease.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","BK4588","XLV","BK4137","LU0029874061.USD","LABU","IBB","TLSA","XBI","BK4585","BK4139","HCSG","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675559978","title":"Tiziana Life Sciences Doses Last Patient in Phase 2 Trial of Intranasal Foralumab in Alzheimer's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2675559978","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675559978?lang=en_us&edition=fundamental","pubTime":"2026-10-16 19:25","pubTimestamp":1792149905,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences  said Friday it has started dosing the last patient under the phase 2 trial of intranasal foralumab in patients with early/mild Alzheimer's disease.The trial is evaluating intranasal foralumab both as monotherapy and in combination with lecanemab or donanemab, with key endpoints such as changes in neuroinflammation, cognitive function and fluid biomarkers, the company said.Tiziana said it expects to release the trial's topline data in Q1 2027.Shares of the company rose more than 1% in recent premarket activity Friday.Price: 1.07, Change: +0.02, Percent Change: +1.90","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675962095","title":"Tiziana Doses Last Patient in Phase 2 Trial of Intranasal Foralumab for Mild Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2675962095","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675962095?lang=en_us&edition=fundamental","pubTime":"2026-10-16 19:00","pubTimestamp":1792148400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261016:nTUA5GNCWS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675723596","title":"Tiziana Life Sciences Ltd: Topline Data are Anticipated to be Announced in Q1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2675723596","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675723596?lang=en_us&edition=fundamental","pubTime":"2026-10-16 19:00","pubTimestamp":1792148400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261016:nTUA5GNCWS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673700002","title":"Tiziana Life Sciences (TLSA) Gets a Buy from BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2673700002","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673700002?lang=en_us&edition=fundamental","pubTime":"2026-10-05 21:35","pubTimestamp":1791207349,"startTime":"0","endTime":"0","summary":"In a report released today, Thomas Shrader from BTIG maintained a Buy rating on Tiziana Life Sciences, with a price target of $7.00. According to T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/tiziana-life-sciences-tlsa-gets-a-buy-from-btig-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/tiziana-life-sciences-tlsa-gets-a-buy-from-btig-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671050012","title":"Tiziana Life Sciences - Submits Request to FDA for Orphan Drug Designation for Intranasal Foralumab for Msa","url":"https://stock-news.laohu8.com/highlight/detail?id=2671050012","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671050012?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:00","pubTimestamp":1790766054,"startTime":"0","endTime":"0","summary":"BRIEF-Tiziana Life Sciences - Submits Request To FDA For Orphan Drug Designation For Intranasal Foralumab For MsaSept 30 (Reuters)-Tiziana Life Sciences LtdTLSA.O:TIZIANA LIFE SCIENCES - SUBMITS REQUE","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nFWN45M0VY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670231179","title":"Tiziana Life announces first 3 participants received first dose in ALS BANYAN","url":"https://stock-news.laohu8.com/highlight/detail?id=2670231179","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670231179?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:10","pubTimestamp":1790593841,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences (TLSA) announced that the first three participants have all received their first dose of intranasal foralumab in the Phase 2a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tiziana-life-announces-first-3-participants-received-first-dose-in-als-banyan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tiziana-life-announces-first-3-participants-received-first-dose-in-als-banyan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670392752","title":"Tiziana Life Sciences Doses First Patients in Phase 2a Intranasal Foralumab ALS Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2670392752","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670392752?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:00","pubTimestamp":1790593223,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences doses first patients in Phase 2a intranasal foralumab ALS trialTiziana Life Sciences dosed the first three participants in a Phase 2a trial of intranasal foralumab in ALS.No resu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL46l6Gl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014013.SGD","IE00BGHQF748.EUR","BK4139","BK4112","TLSA","IE00BQXX3D17.EUR","LU2210150020.SGD","LU2210149790.SGD","BK4585","IE00B64PRP62.GBP","BCDF","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","BK4588","LU0314104364.USD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014039.USD","LU2095319765.USD","IE00BN0W2V16.EUR","SG9999014021.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670392302","title":"Tiziana Life Sciences Announces First Participants Dosed in ALS Banyan Clinical Trial of Intranasal Foralumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2670392302","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670392302?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:00","pubTimestamp":1790593200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nTUA9CM3YJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669143724","title":"Tiziana Life Sciences Price Target Maintained with a $7.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2669143724","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669143724?lang=en_us&edition=fundamental","pubTime":"2026-09-22 18:15","pubTimestamp":1790072100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TLSA/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669150572","title":"Tiziana Life Sciences Completes Phase 2a Inform-MS Last Patient Visit for Intranasal Foralumab in Na-SPMS","url":"https://stock-news.laohu8.com/highlight/detail?id=2669150572","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669150572?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:00","pubTimestamp":1789988434,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences completes Phase 2a INFORM-MS last patient visit for intranasal foralumab in na-SPMSTiziana reported the last patient completed the final visit in its Phase 2a INFORM-MS trial of ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL6nv9KR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669150511","title":"Tiziana Announces Last Patient Completes Last Visit in Phase 2a Inform-MS Trial of Intranasal Foralumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2669150511","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669150511?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:00","pubTimestamp":1789988400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUA5D53JF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668344961","title":"Tiziana Life Sciences signs MOU with KAIMRC in Saudi Arabia","url":"https://stock-news.laohu8.com/highlight/detail?id=2668344961","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668344961?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:15","pubTimestamp":1789643725,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences (TLSA) announced the signing of a memorandum of understanding, or MOU, with the King Abdullah International Medical Research ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tiziana-life-sciences-signs-mou-with-kaimrc-in-saudi-arabia-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tiziana-life-sciences-signs-mou-with-kaimrc-in-saudi-arabia-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668969492","title":"Tiziana Life Sciences Signs MOU at Riyadh Global Medical Biotechnology Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2668969492","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668969492?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:05","pubTimestamp":1789643119,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences signs MOU at Riyadh Global Medical Biotechnology SummitTiziana signed an MOU at the Riyadh Global Medical Biotechnology Summit in Riyadh on September 16, 2026.Agreement targets a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL35lZZf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668969689","title":"Tiziana Life Sciences Announces Signing of Mou with King Abdullah International Medical Research Center","url":"https://stock-news.laohu8.com/highlight/detail?id=2668969689","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668969689?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:00","pubTimestamp":1789642845,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nFWN4590MA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668696960","title":"Tiziana Life Sciences - Mou Covers Clinical Trial of Foralumab and Anti-Cd20 in Rrms Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2668696960","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668696960?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:00","pubTimestamp":1789642845,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nFWN4590MA:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664299875","title":"Tiziana Life Sciences Initiated at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2664299875","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664299875?lang=en_us&edition=fundamental","pubTime":"2026-09-03 18:18","pubTimestamp":1788430680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TLSA/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664873409","title":"Tiziana Life Sciences Ltd : Btig Initiates Coverage with Buy Rating; Price Target $7","url":"https://stock-news.laohu8.com/highlight/detail?id=2664873409","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664873409?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:51","pubTimestamp":1788429094,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V0IG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661323273","title":"Tiziana Life Sciences Launches Phase 2a Banyan Trial of Intranasal Foralumab in ALS","url":"https://stock-news.laohu8.com/highlight/detail?id=2661323273","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661323273?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569233,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences launches Phase 2a BANYAN trial of intranasal foralumab in ALSTiziana Life Sciences announced a Phase 2a BANYAN trial of intranasal foralumab in ALS within the Healey ALS MyMatch ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDLsJD9F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","NDAQ","IE00BQXX3D17.EUR","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","IE00BN0W2W23.USD","SG9999014039.USD","IE00BQXX3C00.GBP","IE00BQXX3F31.USD","LU2210150020.SGD","SG9999014005.SGD","SG9999014013.SGD","BK4588","IE00BN0W2V16.EUR","LU0314104364.USD","BK4585","IE00BKPKM429.USD","SG9999014021.USD","LU2210149790.SGD","BCDF","LU2095319765.USD","TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661273805","title":"Tiziana Life Sciences Announces Poster Presentation on Phase 2a Banyan Clinical Trial of Intranasal Foralumab at ALS Nexus 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2661273805","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661273805?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA8XKWHH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tizianalifesciences.com","stockEarnings":[{"period":"1week","weight":-0.1176},{"period":"1month","weight":0.3635},{"period":"3month","weight":-0.0187},{"period":"6month","weight":-0.1532},{"period":"1year","weight":-0.4802},{"period":"ytd","weight":-0.2953}],"compareEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":0.0122},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.0748},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1193}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti-  receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody for the treatment of IL6-induced inflammation and to treat COVID-19 patients. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.062066},{"month":2,"riseRate":0.125,"avgChangeRate":0.000048},{"month":3,"riseRate":0.375,"avgChangeRate":0.130911},{"month":4,"riseRate":0.625,"avgChangeRate":0.144279},{"month":5,"riseRate":0.5,"avgChangeRate":0.187138},{"month":6,"riseRate":0.375,"avgChangeRate":-0.011823},{"month":7,"riseRate":0.375,"avgChangeRate":0.26158},{"month":8,"riseRate":0.25,"avgChangeRate":-0.130353},{"month":9,"riseRate":0.375,"avgChangeRate":0.001357},{"month":10,"riseRate":0.25,"avgChangeRate":-0.074032},{"month":11,"riseRate":0,"avgChangeRate":-0.127748},{"month":12,"riseRate":0,"avgChangeRate":-0.132657}],"exchange":"NASDAQ","name":"Tiziana Life Sciences PLC","nameEN":"Tiziana Life Sciences PLC","securityTypeName":"DR","adrRate":"1:2"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tiziana Life Sciences PLC(TLSA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Tiziana Life Sciences PLC(TLSA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Tiziana Life Sciences PLC,TLSA,Tiziana Life Sciences PLC股票,Tiziana Life Sciences PLC股票老虎,Tiziana Life Sciences PLC股票老虎国际,Tiziana Life Sciences PLC行情,Tiziana Life Sciences PLC股票行情,Tiziana Life Sciences PLC股价,Tiziana Life Sciences PLC股市,Tiziana Life Sciences PLC股票价格,Tiziana Life Sciences PLC股票交易,Tiziana Life Sciences PLC股票购买,Tiziana Life Sciences PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tiziana Life Sciences PLC(TLSA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Tiziana Life Sciences PLC(TLSA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction